Preliminary evidence of the efficacy of the Reducing Aggressive Driving (RAD) program.


Journal

Journal of safety research
ISSN: 1879-1247
Titre abrégé: J Safety Res
Pays: United States
ID NLM: 1264241

Informations de publication

Date de publication:
09 2022
Historique:
received: 12 12 2021
revised: 21 02 2022
accepted: 14 07 2022
entrez: 28 8 2022
pubmed: 29 8 2022
medline: 31 8 2022
Statut: ppublish

Résumé

Aggressive driving contributes to crashes, which often result in serious or fatal injuries. Efforts to reduce road trauma need to include strategies to reduce emotional and aggressive driving. Thus far, solutions have not comprehensively addressed the reasons why drivers become aggressive. This study provides preliminary evidence of the effectiveness of the Reduce Aggressive driving (RAD) program in improving driver behavior. The RAD is based on group discussion, feedback, and goal setting to encourage more positive responses to triggers for aggressive driving. The aim of this study was to evaluate the delivery of the RAD and its impact on driver anger and aggression. A total of 94 drivers, ranging in age from 18 to 74 years (Mean = 38; SD = 15; 56% males) attended one two-hour online RAD session during which they identified triggers for their aggression and developed individual strategies to avoid aggressive driving. Most (87%) participants agreed that the RAD helped them generate realistic strategies to avoid aggressive driving. A subset of 67 participants provided self-reported anger and aggressive driving tendencies one month, and four months after the RAD. When these were compared to baseline measures taken before participation in the RAD, decreases across all measures were observed. Thus, anger and aggressive driving significantly decreased one month after the RAD, and these decreases were maintained at the four month follow up; providing evidence of the effectiveness of the RAD in reducing these dangerous behaviors. Further research is needed to objectively measure changes in behavior to and support broader roll-out of the RAD program.

Identifiants

pubmed: 36031274
pii: S0022-4375(22)00099-8
doi: 10.1016/j.jsr.2022.07.011
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

438-449

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Amanda N Stephens (AN)

Monash University Accident Research Centre, 21 Alliance Way, Australia. Electronic address: Amanda.stephens@monash.edu.

Sharon Newnam (S)

Monash University Accident Research Centre, 21 Alliance Way, Australia; Queensland University of Technology, School of Psychology and Counselling, Queensland, Australia.

Kristie L Young (KL)

Monash University Accident Research Centre, 21 Alliance Way, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH